## Clinical Presentation: Pseudomonal Wound Infection **Key Point:** The combination of puncture wound, gram-negative oxidase-positive rod with blue-green pigment, and **rapid tissue necrosis with black eschar** is characteristic of *Pseudomonas aeruginosa* infection, particularly in immunocompromised hosts (diabetes, CKD). ## Virulence Factors of *Pseudomonas aeruginosa* *Pseudomonas* produces multiple toxins and virulence factors: | Virulence Factor | Mechanism | Clinical Effect | |------------------|-----------|----------------| | **Exotoxin A (ETA)** | ADP-ribosylates EF-2 → inhibits protein synthesis | Massive tissue necrosis, rapid progression | | Elastase | Degrades elastin in blood vessel walls | Vascular invasion, hemorrhage, necrosis | | Alkaline protease | Proteolytic degradation of tissue | Tissue destruction | | Pyocyanin | Reactive oxygen species generation | Oxidative damage, tissue injury | | LPS endotoxin | TLR4 activation → systemic inflammation | Sepsis, shock (but not primary necrosis) | | Pili | Adhesion and biofilm | Persistence, chronic infection | ## Why Exotoxin A Is the Answer **High-Yield:** Exotoxin A (ETA) is the **most potent virulence factor** in *Pseudomonas aeruginosa* and is responsible for the **rapid, extensive tissue necrosis** seen in this case. ### Mechanism of ETA 1. **Binding:** ETA binds to heparin-binding EGF-like growth factor (HB-EGF) on host cells 2. **Internalization:** Receptor-mediated endocytosis 3. **Translocation:** pH-dependent translocation of catalytic domain into cytoplasm 4. **Catalytic action:** ADP-ribosylates elongation factor 2 (EF-2) 5. **Outcome:** Irreversible inhibition of protein synthesis → **rapid cell death and tissue necrosis** **Clinical Pearl:** The **black eschar** (tissue necrosis) with minimal inflammatory infiltrate is pathognomonic for ETA-mediated injury. Unlike LPS-driven sepsis (which triggers robust TNF-α and inflammation), ETA causes direct cytotoxic damage with tissue death preceding inflammation. ### Comparison: ETA vs. Other Toxins ```mermaid flowchart TD A["Pseudomonas aeruginosa Virulence"]:::outcome --> B["Exotoxin A (ETA)"]:::action A --> C["Elastase & Alkaline Protease"]:::action A --> D["LPS Endotoxin"]:::action A --> E["Pili & Biofilm"]:::action B --> B1["ADP-ribosylates EF-2<br/>Inhibits protein synthesis<br/>RAPID NECROSIS"]:::urgent C --> C1["Vascular degradation<br/>Hemorrhage + necrosis"]:::urgent D --> D1["Systemic inflammation<br/>TNF-α, IL-6 release<br/>Sepsis/shock"]:::urgent E --> E1["Adhesion<br/>Chronic biofilm<br/>Resistance"]:::action ``` **Mnemonic:** **ETA-EF2** — **E**xotoxin A inactivates **E**longation **F**actor **2**, causing rapid cell death. ## Why This Patient Has Severe Necrosis The patient's **diabetes and CKD** impair: - Neutrophil function and chemotaxis - Complement activation - Wound healing - Bacterial clearance These defects allow *Pseudomonas* to proliferate and produce high levels of ETA, leading to accelerated tissue destruction and the characteristic black eschar. [cite:Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Ch 219; Harrison 21e Ch 157]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.